These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11707995)
1. [Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions]. Ishida H; Fujioka M; Ohsawa T; Takeuchi I; Nakada H; Ishizuka N; Yokoyama M; Inokuma S; Yamada H; Odaka A; Hoshino T; Murata N; Hashimoto D; Matsumoto Y; Miura T Gan To Kagaku Ryoho; 2001 Oct; 28(11):1624-7. PubMed ID: 11707995 [TBL] [Abstract][Full Text] [Related]
2. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase]. Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479 [TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis. Ikeguchi M; Makino M; Kaibara N Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361 [TBL] [Abstract][Full Text] [Related]
4. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy. Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613 [TBL] [Abstract][Full Text] [Related]
5. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
6. 5-Fluorouracil-related gene expression in hepatic artery infusion-treated patients with hepatic metastases from colorectal carcinomas. Sameshima S; Tomozawa S; Horikoshi H; Motegi K; Hirayama I; Koketsu S; Okada T; Kojima M; Kon Y; Sawada T Anticancer Res; 2008; 28(1B):389-93. PubMed ID: 18383874 [TBL] [Abstract][Full Text] [Related]
7. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674 [TBL] [Abstract][Full Text] [Related]
8. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine. Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of determinations of dihydropyrimidine dehydrogenase levels in primary and hepatic lesions of colorectal cancer patients]. Ishida H; Hashimoto D; Inokuma S; Takeuchi I; Nakada H; Ohsawa T; Hoshino T; Murata N; Fujioka M; Idezuki Y Gan To Kagaku Ryoho; 2000 Oct; 27(12):1879-82. PubMed ID: 11086435 [TBL] [Abstract][Full Text] [Related]
10. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study). Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805 [TBL] [Abstract][Full Text] [Related]
11. [Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor]. Ishida H; Takeuchi I; Ohsawa T; Nakada H; Ishizuka N; Yokoyama M; Inokuma S; Suzuki T; Yamada H; Odaka A; Hoshino T; Murata N; Hashimoto D; Matsumoto Y; Miura T Gan To Kagaku Ryoho; 2002 Nov; 29(12):2267-70. PubMed ID: 12484051 [TBL] [Abstract][Full Text] [Related]
12. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer. Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700 [TBL] [Abstract][Full Text] [Related]
13. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis. Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742 [TBL] [Abstract][Full Text] [Related]
14. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up. Lassmann S; Hennig M; Rosenberg R; Nährig J; Schreglmann J; Krause F; Poignee-Heger M; Nekarda H; Höfler H; Werner M Int J Colorectal Dis; 2006 Apr; 21(3):238-47. PubMed ID: 16132996 [TBL] [Abstract][Full Text] [Related]
15. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer. Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024 [TBL] [Abstract][Full Text] [Related]
16. [Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer]. Ishida H; Ohsawa T; Nakada H; Yokoyama M; Inokuma S; Shirakawa K; Yamada H; Hashimoto D Gan To Kagaku Ryoho; 2004 Jun; 31(6):883-7. PubMed ID: 15222105 [TBL] [Abstract][Full Text] [Related]
17. [Estimation of level of enzyme induction of thymidine phosphorylase, dihydropyrimidine dehydrogenase, and thymidylate synthase in primary and recurrent breast cancer]. Morimoto K; Koh M Gan To Kagaku Ryoho; 2004 Apr; 31(4):529-38. PubMed ID: 15114696 [TBL] [Abstract][Full Text] [Related]
18. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil]. Ishibashi K; Sobajima J; Ishiguro T; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H Gan To Kagaku Ryoho; 2009 Nov; 36(12):2232-5. PubMed ID: 20037380 [TBL] [Abstract][Full Text] [Related]
19. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer. Meropol NJ; Gold PJ; Diasio RB; Andria M; Dhami M; Godfrey T; Kovatich AJ; Lund KA; Mitchell E; Schwarting R J Clin Oncol; 2006 Sep; 24(25):4069-77. PubMed ID: 16943524 [TBL] [Abstract][Full Text] [Related]
20. [Tumoral levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in elderly colorectal cancer patients]. Ishida H; Takeuchi I; Inokuma S; Nakada H; Ohsawa T; Hoshino T; Murata N; Fujioka M; Hashimoto D; Idezuki Y Gan To Kagaku Ryoho; 2001 Jun; 28(6):809-14. PubMed ID: 11432349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]